JH-EsoAd1- Esophageal Cancer Cell Line

Abstract (Set) Esophageal adenocarcinoma currently has one of the most rapidly increasing tumor incidences in the United States, with the vast majority of cases occurring on the backdrop of metaplastic epithelium (Barrett esophagus). The availability of appropriate cell line models is essential for maintaining the pace of esophageal cancer research and for pre-clinical validation of new therapeutic modalities. JHU scientists have established and characterized an esophageal cancer cell line, JH-EsoAd1, from a patient with Barrett-associated adenocarcinoma. Description (Set) Proposed Use (Set) This cell line is useful for esophageal cancer research to ameliorate the scarcity of preclinical models in this disease.

Inventor(s): Eshleman, James Richard

Type of Offer: Licensing



« More Medical Patents

---